HSB-888

N/A

Report date: 2024/01/25 14:20:27
NME

Base Information

Drug NameHSB-888
Drug Alias NameHSB-888
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell death stimulantsDNA intercalators
TargetsDNA
Therapy Area/IndicationsOsteosarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTharimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesTharimmune Inc
Inactive CompaniesN/A
Active IndicationsOsteosarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A